Literature DB >> 9774750

Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases.

A B Brucker1, H Vollert-Rogenhofer, M Wagner, K Stieglbauer, S Felber, J Trenkler, E Deisenhammer, F Aichner.   

Abstract

The only randomized data on heparin treatment in acute cerebral sinus venous thrombosis (CSVT) are derived from a small number of patients. The rate of intracranial hemorrhages as a complication of high-dose heparin treatment is still unknown. This retrospective study evaluates the clinical features, neuroimaging monitoring and outcome of 42 patients with proven CSVT. Diagnosis was established by DSA, CT, MR tomography and MR angiography. All patients received heparin intravenously guided by doubling the aPTT value for 3 weeks, followed by oral anticoagulation. Partial or complete recanalization was found in 36 cases. 40 patients improved clinically, in 26 of them complete recovery was observed. One patient deteriorated and developed an apallic syndrome, one further patient died of septic multiorgan failure. Only in one patient was hemorrhagic transformation of infarcted brain tissue observed but without clinical deterioration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774750     DOI: 10.1159/000015876

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  19 in total

1.  Cerebral Venous Thrombosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 2.  [Current controversies in the diagnosis and management of cerebral venous and dural sinus thrombosis].

Authors:  S Schwarz; M Daffertshofer; T Schwarz; D Georgiadis; R W Baumgartner; M Hennerici; C Groden
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

Review 3.  Cerebral venous sinus thrombosis.

Authors:  Shelley Renowden
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

4.  Clinical Presentation, Imaging and Treatment of Cerebral Venous Thrombosis (CVT).

Authors:  S K Lee; B S Kim; K G Terbrugge
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

Review 5.  Anticoagulation for cerebral venous sinus thrombosis.

Authors:  Jonathan Coutinho; Sebastiaan Ftm de Bruijn; Gabrielle Deveber; Jan Stam
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

Review 6.  Deep Cerebral Venous Thrombosis Treatment : Endovascular Case using Aspiration and Review of the Various Treatment Modalities.

Authors:  Leonard Ll Yeo; Priscillia Ps Lye; Kong Wan Yee; Yang Cunli; Tu Tian Ming; Andrew Fw Ho; Vijay K Sharma; Bernard Pl Chan; Benjamin Yq Tan; Anil Gopinathan
Journal:  Clin Neuroradiol       Date:  2020-06-11       Impact factor: 3.649

7.  Treatment of progressive cerebral sinuses thrombosis with local thrombolysis.

Authors:  R Mohammadian; B Sohrabi; R Mansourizadeh; F Mohammadian; A Nazempour; M Farhoudi; A Pashapour; A A Taher Aghdam; A Hashemzadeh; M Pourkakrodi
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

8.  Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment.

Authors:  F Masuhr; S Mehraein
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

9.  Safety and feasibility of subcutaneous low molecular weight heparin for cerebral venous sinus thrombosis.

Authors:  Ji Seon Kim; Seong Hae Jeong; Dae Hyun Kim; Jei Kim
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

10.  Cerebral Venous Thrombosis.

Authors:  Valérie Biousse; Frank Tong; Nancy J. Newman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.